Daily Archives: September 4, 2014

ISS and Glass Lewis Recommend that Chindex International, Inc. Shareholders Vote “FOR” the Proposed Going-Private Transaction

BETHESDA, Md., September 4, 2014 /PRNewswire/ — Chindex International, Inc. (“Chindex” or the “Company”) (Nasdaq: CHDX) announced today that the independent proxy advisory firms, Institutional Shareholder Services Inc. (“ISS”) and…

China Biologic Completes Transaction to Acquire Additional Equity Stake in Guizhou Taibang

BEIJING, September 4, 2014 /PRNewswire/ — China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that it…

New Platforms Enhance AMRI’s Discovery Biology Offerings

ALBANY, N.Y., Sept. 4, 2014 /PRNewswire/ — AMRI (NASDAQ: AMRI) announced today that it has expanded into the protein market, with an initial focus on protein expression and purification. The…

First Tele-health Programme for Heart Failure Patients in Singapore Enables Patients to Better Manage their Health and Reduce Hospitalisation

SINGAPORE, Sept. 4, 2014 /PRNewswire/ — The Eastern Health Alliance (EH Alliance) and Changi General Hospital (CGH) have partnered Philips Healthcare (Philips) to pilot Singapore’s first tele-health programme for heart…

New Data Presented at WCCS Confirm High Long-term Efficacy of Picato® in Patients with Actinic Keratosis

BALLERUP, Denmark, Sept. 4, 2014 /PRNewswire/ — Not for US media The digital press release with multimedia content can be accessed here: http://www.multivu.com/players/uk/7276254-WCCS-Picato-actinickeratosis/ New data from the international FIELD Study…